Haider Thaer Abdulhameed Almuqdadi

Dr. Haider Thaer Abdulhameed Almuqdadi

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 May 2025 in Journal of Molecular Structure
Verified
Journal Article
Closed access
ABAvijit Bhakta
Avijit Bhakta
SKSonam Kandola
Sonam Kandola
Asghar AliAsghar Ali
Asghar Ali
MKMohan Kamthan
Mohan Kamthan
HAHaider Thaer Abdulhameed Almuqdadi
Haider Thaer Abdulhameed Almuqdadi
NANaseem Ahmed
Naseem Ahmed

21 December 2024 in Journal of Molecular Structure
Verified
Journal Article
Closed access
AAAnam Arif
Anam Arif
SASaigal
Saigal
HAHaider Thaer Abdulhameed Almuqdadi
Haider Thaer Abdulhameed Almuqdadi
MSMohammad Shakir
Mohammad Shakir
AAAkil Ahmad
Akil Ahmad
MKMusawwer Khan
Musawwer Khan

22 May 2024 in Molecular Diversity
Verified
Journal Article
Closed access
PDF file
SKSumaiya Kifayat
Sumaiya Kifayat
HAHaider Thaer Abdulhameed Almuqdadi
Haider Thaer Abdulhameed Almuqdadi
RSRavindra pal Singh
Ravindra pal Singh
MSMithilesh Singh
Mithilesh Singh
MAMOHAMMAD ABID
MOHAMMAD ABID
Bharat Kumar Reddy SanapalliBharat Kumar Reddy Sanapalli
Bharat Kumar Reddy Sanapalli

5 September 2024 in Future Microbiology
Verified
Journal Article
Closed access
PMPreeti Maurya
Preeti Maurya
MKMohit Kumar
Mohit Kumar
RJRavi Jain
Ravi Jain
HAHaider Thaer Abdulhameed Almuqdadi
Haider Thaer Abdulhameed Almuqdadi
HSHarshita Singh
Harshita Singh
SSShailja Singh
Shailja Singh
Aim: To assess the functional relevance of a putative Major Facilitator Superfamily protein (PF3D7_0210300; 'PfMFSDT') as a drug transporter, using Candida glabrata for orthologous protein expression. Methods: Complementary Determining Sequence encoding PfMFSDT was integrated into the genome of genetically engineered C. glabrata strain MSY8 via homologous recombination, followed by assessing its functional relevance as a drug transporter. Results & conclusion: The modified C. glabrata strain exhibited plasma membrane localization of PfMFSDT and characteristics of an Major Facilitator Superfamily transporter, conferring resistance to antifungals, ketoconazole and itraconazole. The nanomolar inhibitory effects of the drugs on the intra-erythrocytic growth of Plasmodium falciparum highlight their antimalarial properties. This study proposes PfMFSDT as a drug transporter, expanding the repertoire of the currently known antimalarial 'resistome'.

12 June 2025 in Journal of Biomolecular Structure and Dynamics
Verified
Journal Article
Closed access
HAHaider Thaer Abdulhameed Almuqdadi
Haider Thaer Abdulhameed Almuqdadi
MSMohd. Shakir
Mohd. Shakir
RSRumaisha Shoaib
Rumaisha Shoaib
JAJihad Alrehaili
Jihad Alrehaili
Razique AnwerRazique Anwer
Razique Anwer
MAMOHAMMAD ABID
MOHAMMAD ABID
Malaria remains a critical global health issue, particularly in tropical and subtropical regions. Understanding its biology and epidemiology is vital for developing effective prevention and control strategies. Falcipain-2 (FP-2), a cysteine protease in Plasmodium falciparum, the deadliest malaria parasite, is essential for parasite survival in red blood cells, making it an attractive drug target. Inhibiting FP-2 disrupts key metabolic processes, leading to parasite death, offering a promising antimalarial drug development avenue. This study utilized computational approaches to design novel antimalarials. We prepared large fragment libraries, Enamine (∼220,174 fragments) and ChemDiv (∼18,713 fragments), for virtual screening against FP-2 (PDB ID: 6JW9). Fragments with binding free energies ≤ -4.0 kcal/mol were selected and evolved into drug-like ligands. SP and XP docking-based screenings prioritized these ligands, refined further using MM-GBSA calculations. Promising ligands underwent 100 ns molecular dynamics simulations to assess conformational changes and complex stability. This study identified two viable inhibitors, T4 and A3, with high affinity, stability, and selectivity towards FP-2 compared to E64.Following computational studies, compound A3 and its ten analogues (KA-series) were synthesized and characterized by using multi-spectroscopic techniques with high purity confirmed by LC-MS. Biological testing against P. falciparum 3D7 strain revealed KA-5 as the most potent compound with an IC50 value of 3.0 μM. Future work will involve synthesizing additional analogue series for an extensive structure-activity relationship (SAR) study. Further experimental validation is essential to develop these compounds as effective therapeutic agents for malaria treatment.

13 February 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
IEIkponmwosa Evbuomwan
Ikponmwosa Evbuomwan
HAHaider Thaer Abdulhameed Almuqdadi
Haider Thaer Abdulhameed Almuqdadi
EIEdema Enogiomwan Imalele
Edema Enogiomwan Imalele
OAOmokolade Oluwaseyi Alejolowo
Omokolade Oluwaseyi Alejolowo
CNCharles Obiora Nwonuma
Charles Obiora Nwonuma
OAOluyomi Stephen Adeyemi
Oluyomi Stephen Adeyemi
Malaria remains a persistent global health challenge, driven largely by the emergence of drug-resistant Plasmodium falciparum strains, underscoring the need for new molecular scaffolds targeting essential parasite proteins. Natural products provide structurally diverse bioactive compounds, yet the molecular interaction mechanisms of many plant-derived metabolites remain insufficiently characterized. Here, we investigate the binding characteristics, conformational stability, and physicochemical properties of nauclefine, an indole alkaloid from Nauclea latifolia, against two structurally and functionally distinct P. falciparum proteins (PfEMP1 and PfDHFR-TS) using integrated computational approaches. ADMET analysis was performed to assess the pharmacokinetic and drug-likeness of N. latifolia phytoconstituents. Following the ADMET study, nauclefine was selected for further analyses. Molecular docking was employed to elucidate the interactions of nauclefine with the proteins. MD simulations were conducted to evaluate the stability and flexibility of the protein-ligand complexes, and MM/PBSA calculations were used to estimate binding free energies and their energetic components. ADMET predictions suggested acceptable physicochemical properties and no major predicted toxicity alerts. Docking results revealed favorable binding orientations of nauclefine within the active regions of both targets, stabilized by a combination of hydrophobic contacts and H-bonding interactions with conserved residues. MD simulations demonstrated stable complex formation over the 100-ns simulation period, characterized by low root-mean-square deviations and limited fluctuations. MM/PBSA analyses indicated thermodynamically favorable binding. These findings provide molecular-level insights into the interaction behavior of nauclefine with key P. falciparum proteins, supporting its potential as a structurally relevant scaffold for further molecular optimization and experimental investigation.